CAPTRUST Financial Advisors’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88.1K Buy
30,592
+18,502
+153% +$47K ﹤0.01% 3059
2026
Q1
$23.7K Buy
+12,090
New +$28.4K ﹤0.01% 2952
2022
Q3
Sell
-897
Closed -$5K 2830
2022
Q2
$5K Hold
897
﹤0.01% 4080
2022
Q1
$17K Hold
897
﹤0.01% 3486
2021
Q4
$29K Sell
897
-646
-42% -$26K ﹤0.01% 3042
2021
Q3
$63K Sell
1,543
-9,354
-86% -$339K ﹤0.01% 2426
2021
Q2
$392K Buy
10,897
+9,900
+993% +$365K ﹤0.01% 1105
2021
Q1
$39K Buy
997
+497
+99% +$22.4K ﹤0.01% 2587
2020
Q4
$20K Sell
500
-525
-51% -$24.1K ﹤0.01% 2251
2020
Q3
$51K Buy
+1,025
New +$54.3K ﹤0.01% 1616

Other funds holding GDRX

CAPTRUST Financial Advisors's GDRX Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its GoodRx Holdings (GDRX) stake by 153% in Q2 2026, buying an estimated $47K and bringing the position to 30,592 shares worth $88.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3059.

CAPTRUST Financial Advisors first reported a position in GDRX in Q3 2020 and has held it in 10 quarters since. The position peaked at $392K in Q2 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • CAPTRUST Financial Advisors held 30,592 shares of GoodRx Holdings worth $88.1K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 18,502 GoodRx Holdings shares in Q2 2026, an estimated $47K.
  • GoodRx Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3059 holding.
  • CAPTRUST Financial Advisors first reported a position in GoodRx Holdings in Q3 2020 and has held it in 10 quarters since.
  • CAPTRUST Financial Advisors's GoodRx Holdings position peaked at $392K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.